ViewIt@LU

Kidney outcomes associated with SGLT2 inhibitors versus other glucose-lowering drugs in real-world clinical practice: the Japan chronic kidney disease database

H Nagasu, Y Yano, H Kanegae, HJL Heerspink… - Diabetes …, 2021 - Am Diabetes Assoc
OBJECTIVE Randomized controlled trials have shown kidney-protective effects of sodium–
glucose cotransporter 2 (SGLT2) inhibitors, and clinical practice databases have suggested …
被引用次数：60 相关文章 Web of Science: 43
ViewIt@LU

Kidney outcomes associated with SGLT2 inhibitors versus other glucose-lowering drugs in real-world clinical practice: the japan chronic kidney disease database

H Nagasu, Y Yano, H Kanegae… - Diabetes …, 2021 - kyushu-u.elsevierpure.com
OBJECTIVE Randomized controlled trials have shown kidney-protective effects of
sodiumglucose cotransporter 2 (SGLT2) inhibitors, and clinical practice databases have …
ViewIt@LU

Kidney outcomes associated with SGLT2 inhibitors versus other glucose-lowering drugs in real-world clinical practice: the japan chronic kidney disease database

H Nagasu, Y Yano, H Kanegae… - Diabetes …, 2021 - kyushu-u.pure.elsevier.com
OBJECTIVE Randomized controlled trials have shown kidney-protective effects of
sodiumglucose cotransporter 2 (SGLT2) inhibitors, and clinical practice databases have …
ViewIt@LU

Kidney Outcomes Associated With SGLT2 Inhibitors Versus Other Glucose-Lowering Drugs in Real-world Clinical Practice: The Japan Chronic Kidney Disease …

H Nagasu, Y Yano, H Kanegae… - Diabetes …, 2021 - okayama.elsevierpure.com
OBJECTIVE: Randomized controlled trials have shown kidney-protective effects of sodium-
glucose cotransporter 2 (SGLT2) inhibitors, and clinical practice databases have suggested …
ViewIt@LU

Kidney Outcomes Associated With SGLT2 Inhibitors Versus Other Glucose-Lowering Drugs in Real-world Clinical Practice: The Japan Chronic Kidney Disease …

H Nagasu, Y Yano, H Kanegae, HJL Heerspink… - Diabetes …, 2021 - europepmc.org
Objective Randomized controlled trials have shown kidney-protective effects of sodium-
glucose cotransporter 2 (SGLT2) inhibitors, and clinical practice databases have suggested …
ViewIt@LU

Kidney Outcomes Associated With SGLT2 Inhibitors Versus Other Glucose-Lowering Drugs in Real-world Clinical Practice: The Japan Chronic Kidney Disease …

H Nagasu, Y Yano, H Kanegae, HJL Heerspink… - Diabetes Care, 2021 - cir.nii.ac.jp
抄録< jats: sec>< jats: title> OBJECTIVE</jats: title>< jats: p> Randomized controlled trials
have shown kidney-protective effects of sodium–glucose cotransporter 2 (SGLT2) inhibitors …
ViewIt@LU

Kidney Outcomes Associated With SGLT2 Inhibitors Versus Other Glucose-Lowering Drugs in Real-world Clinical Practice: The Japan Chronic Kidney Disease …

H Nagasu, Y Yano, H Kanegae… - Diabetes …, 2021 - pubmed.ncbi.nlm.nih.gov
Objective Randomized controlled trials have shown kidney-protective effects of sodium-
glucose cotransporter 2 (SGLT2) inhibitors, and clinical practice databases have suggested …
[HTML] nih.govViewIt@LU

[HTML][HTML] Kidney Outcomes Associated With SGLT2 Inhibitors Versus Other Glucose-Lowering Drugs in Real-world Clinical Practice: The Japan Chronic Kidney …

H Nagasu, Y Yano, H Kanegae, HJL Heerspink… - Diabetes …, 2021 - ncbi.nlm.nih.gov
OBJECTIVE Randomized controlled trials have shown kidney-protective effects of sodium–
glucose cotransporter 2 (SGLT2) inhibitors, and clinical practice databases have suggested …
ViewIt@LU

Kidney Outcomes Associated With SGLT2 Inhibitors Versus Other Glucose-Lowering Drugs in Real-world Clinical Practice: The Japan Chronic Kidney Disease …

H Nagasu, Y Yano, H Kanegae… - Diabetes …, 2021 - okayama.elsevierpure.com
OBJECTIVE: Randomized controlled trials have shown kidney-protective effects of sodium-
glucose cotransporter 2 (SGLT2) inhibitors, and clinical practice databases have suggested …